Phaseline

Companies › Green Cross Wellbeing

Green Cross Wellbeing: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 3; Gastroenterology.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
LAENNEC (Human Placenta Hydrolysate) IV
Human placenta hydrolysate
–Phase 3Chronic Liver Disease–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06493799LAENNEC (Human Placenta Hydrolysate) IVPhase 3Chronic Liver DiseaseGastroenterologyMar 2026

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Elgan Pharma Cinclus Pharma Holding Norgine Inventiva Pharma NorthSea Therapeutics

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.